America Pouchitis Treatment Market Research Report Information By Treatment (Antibiotics (Ciprofloxacin, Metronidazole, Rifaximin), Probiotics, and others (Budenoside, Immunosuppressive Therapy)), End Users (Hospitals & Clinics, Institutes) – Forecast till 2032

1 Report Prologue

2 Market Introduction

2.1 Definition 11

2.2 Scope of Study 11

2.3 Research Objective 11

2.4 Assumptions & Limitations 12

2.4.1 Assumptions 12

2.4.2 Limitations 12

2.5 Market Structure 12

3 Research Methodology

3.1.1 Primary Research Methodology 14

3.1.2 Data points received from the Doctors/ Gastrologist: 14

3.1.3 Data points received from the Manufacturer/ Pharmaceutical Companies: 14

3.1.4 Data points received from Hospitals, Clinics: 15

3.1.5 Secondary Research Methodology 16

3.1.6 Market Share Analysis 19

3.1.7 Trade Analysis 19

3.1.8 Market Pricing Approach 19

4 Market Factor Analysis

4.1 Value Chain Analysis 20

4.1.1 R&D 20

4.1.2 Manufacturing 21

4.1.3 Distribution & Sales 21

4.1.4 Post-Sales Monitoring 21

4.2 Porter’s Five Forces Model 22

4.2.1 Bargaining Power of Suppliers 22

4.2.2 Bargaining Power of Buyers 23

4.2.3 Threat of New Entrant 23

4.2.4 Threat of Substitute 23

4.2.5 Intensity of Rivalry 23

4.3 Demand & Supply: Gap Analysis 24

4.4 Pricing Analysis 24

4.5 Investment Opportunity Analysis 24

5 Market Dynamics

5.1 Introduction 26

5.2 Drivers 27

5.2.1 Rising prevalence of Ulcerative Colitis (35%) 27

5.2.2 Increasing need for Ileal Pouch–Anal Anastomosis procedure (30%) 28

5.2.3 Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) (20%) 29

5.2.4 Rising Geriatric Population (15%) 30

5.3 Restraints 31

5.3.1 Side effects of the available treatment options (65%) 31

5.3.2 Stringent FDA Regulations (35%) 32

5.4 Opportunities 33

5.4.1 Unmet Medical Need in Pouchitis Treatment 33

5.5 Mega Trends 33

5.5.1 Rising Research Funding 33

5.6 Pipeline Analysis 33

5.6.1 Alicaforsen 33

5.6.2 Vedolizumab 34

6 Americas pouchitis treatment market by Treatment

6.1 Introduction 35

6.2 Antibiotic 37

6.3 Probiotics 38

6.4 Others 38

7 Americas pouchitis treatment market by End User

7.1 Introduction 39

7.2 Hospitals & Clinics 40

7.3 Research Institutes 40

8 Americas pouchitis treatment market by Region

8.1 Introduction 41

8.2 North America 43

8.2.1 U.S. 45

8.2.2 Canada 46

8.3 South America 47

9 Company Landscape

9.1 Company Analysis 49

9.2 Competitive Landscape 50

10 Company Profiles

10.1 Pfizer 52

10.1.1 Company Overview 52

10.1.2 Financials 52

10.1.3 Products 52

10.1.4 Strategy 52

10.1.5 Key Developments 52

10.2 Abbott 53

10.2.1 Company Overview 53

10.2.2 Financials 53

10.2.3 Products 53

10.2.4 Strategy 53

10.2.5 Key Developments 53

10.3 Allergan Plc 54

10.3.1 Company Overview 54

10.3.2 Financials 54

10.3.3 Products 54

10.3.4 Strategy 54

10.3.5 Key Developments 54

10.4 Bayer 55

10.4.1 Company Overview 55

10.4.2 Financials 55

10.4.3 Products 55

10.4.4 Strategy 55

10.4.5 Key Developments 55

10.5 Takeda 56

10.5.1 Company Overview 56

10.5.2 Financials 56

10.5.3 Products 56

10.5.4 Strategy 56

10.5.5 Key Developments 56

10.6 Alfa sigma 57

10.6.1 Company Overview 57

10.6.2 Financials 57

10.6.3 Products 57

10.6.4 Strategy 57

10.6.5 Key Developments 57

10.7 Atlantic Healthcare 58

10.7.1 Company Overview 58

10.7.2 Financials 58

10.7.3 Products 58

10.7.4 Strategy 58

10.7.5 Key Developments 58

10.8 Tillotts Pharma AG 59

10.8.1 Company Overview 59

10.8.2 Financials 59

10.8.3 Products 59

10.8.4 Strategy 59

10.8.5 Key Developments 59

11 List of Tables

TABLE 1 PRIMARY INTERVIEWS 15

TABLE 2 AMERICAS POUCHITIS TREATMENT MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 36

TABLE 3 AMERICAS POUCHITIS TREATMENT MARKET BY ANTIBIOTIC TYPE, 2020 TO 2027 (USD MILLION) 37

TABLE 4 AMERICAS POUCHITIS TREATMENT MARKET FOR ANTIBIOTICS BY REGION, 2020 TO 2027 (USD MILLION) 37

TABLE 5 AMERICAS POUCHITIS TREATMENT MARKET FOR PROBIOTICS BY REGION, 2020 TO 2027 (USD MILLION) 38

TABLE 6 AMERICAS POUCHITIS TREATMENT MARKET BY END USER, 2020 TO 2027 (USD MILLION) 40

TABLE 7 AMERICAS POUCHITIS TREATMENT MARKET FOR HOSPITALS & CLINICS BY REGION, 2020 TO 2027 (USD MILLION) 40

TABLE 8 AMERICAS POUCHITIS TREATMENT MARKET FOR RESEARCH INSTITUTES BY REGION, 2020 TO 2027 (USD MILLION) 40

TABLE 9 AMERICAS POUCHITIS TREATMENT MARKET BY REGION, 2020 TO 2027 (USD MILLION) 42

TABLE 10 NORTH AMERICAS POUCHITIS TREATMENT MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 43

TABLE 11 NORTH AMERICAS POUCHITIS TREATMENT MARKET BY ANTIBIOTIC TYPE, 2020 TO 2027 (USD MILLION) 43

TABLE 12 NORTH AMERICAS POUCHITIS TREATMENT MARKET BY END USER, 2020 TO 2027 (USD MILLION) 44

TABLE 13 NORTH AMERICAS POUCHITIS TREATMENT MARKET BY COUNTRY, 2020 (%) 44

TABLE 14 NORTH AMERICAS POUCHITIS TREATMENT MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 44

TABLE 15 U.S. POUCHITIS TREATMENT MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 45

TABLE 16 U.S. POUCHITIS TREATMENT MARKET BY ANTIBIOTIC TYPE, 2020 TO 2027 (USD MILLION) 45

TABLE 17 U.S. POUCHITIS TREATMENT MARKET BY END USER, 2020 TO 2027 (USD MILLION) 45

TABLE 18 CANADA POUCHITIS TREATMENT MARKET BY TREATMENT, 2020 TO 2027 (USD MILLION) 46

TABLE 19 CANADA POUCHITIS TREATMENT MARKET BY ANTIBIOTIC TYPE, 2020 TO 2027 (USD MILLION) 46

TABLE 20 CANADA POUCHITIS TREATMENT MARKET BY END USER, 2020 TO 2027 (USD MILLION) 46

TABLE 21 SOUTH AMERICAS POUCHITIS TREATMENT MARKET BY ANTIBIOTIC TYPE, 2020 TO 2027 (USD MILLION) 47

TABLE 22 SOUTH AMERICAS POUCHITIS TREATMENT MARKET BY ANTIBIOTIC TYPE, 2020 TO 2027 (USD MILLION) 47

TABLE 23 SOUTH AMERICAS POUCHITIS TREATMENT MARKET BY END USER, 2020 TO 2027 (USD MILLION) 48

12 List of Figures

FIGURE 1 AMERICAS POUCHITIS TREATMENT MARKET BY TREATMENT, 2020 (%) 10

FIGURE 2 AMERICAS POUCHITIS TREATMENT MARKET, BY END USER, 2020 (%) 10

FIGURE 3 MARKET STRUCTURE OF AMERICAS POUCHITIS TREATMENT MARKET 12

FIGURE 4 RESEARCH METHODOLOGY 13

FIGURE 5 DATA TRIANGULATION PRIMARY 16

FIGURE 6 DATA TRIANGULATION METHOD 18

FIGURE 7 VALUE CHAIN: POUCHITIS TREATMENT MARKET 20

FIGURE 8 PORTERS FIVE FORCES ANALYSIS OF AMERICAS POUCHITIS TREATMENT MARKET 22

FIGURE 9 MARKET DYNAMICS: AMERICAS POUCHITIS TREATMENT MARKET 26

FIGURE 10 AMERICAS POUCHITIS TREATMENT MARKET BY TREATMENT, 2020 & 2027 (USD MILLION) 36

FIGURE 11 AMERICAS POUCHITIS TREATMENT MARKET BY END USER, 2020 & 2027 (USD MILLION) 39

FIGURE 12 AMERICAS POUCHITIS TREATMENT MARKET BY REGION, 2020 (%) 42